Hester Biosciences Limited (HESTERBIO) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.050x

Based on the latest financial reports, Hester Biosciences Limited (HESTERBIO) has a cash flow conversion efficiency ratio of 0.050x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs174.78 Million ≈ $1.89 Million USD) by net assets (Rs3.51 Billion ≈ $37.96 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See HESTERBIO defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Hester Biosciences Limited - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Hester Biosciences Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Hester Biosciences Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hester Biosciences Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
LifeMD Inc
NASDAQ:LFMD
-0.142x
Ames National Corporation
NASDAQ:ATLO
0.013x
SHANGH.DAZ.PUBL.UTIL.YC 1
F:6WL
N/A
Koza Polyester Sanayi ve Ticaret A.S.
IS:KOPOL
-0.001x
Hocheng Corp
TW:1810
-0.008x
Golden Ventures Leasehold Real Estate Investment Trust
BK:GVREIT
0.026x
Bien Yapi Urunleri Sanayi Turizm ve Ticaret A.S.
IS:BIENY
0.146x
AVerMedia Technologies Inc
TW:2417
0.036x

Annual Cash Flow Conversion Efficiency for Hester Biosciences Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Hester Biosciences Limited from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see Hester Biosciences Limited stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs3.27 Billion
≈ $35.33 Million
Rs645.11 Million
≈ $6.98 Million
0.197x +24.27%
2024-03-31 Rs3.03 Billion
≈ $32.75 Million
Rs481.34 Million
≈ $5.21 Million
0.159x +96.92%
2023-03-31 Rs2.92 Billion
≈ $31.62 Million
Rs235.96 Million
≈ $2.55 Million
0.081x +145.00%
2022-03-31 Rs2.67 Billion
≈ $28.92 Million
Rs88.08 Million
≈ $952.55K
0.033x -86.61%
2021-03-31 Rs2.36 Billion
≈ $25.52 Million
Rs580.53 Million
≈ $6.28 Million
0.246x +32.67%
2020-03-31 Rs2.06 Billion
≈ $22.33 Million
Rs382.92 Million
≈ $4.14 Million
0.185x -30.32%
2019-03-31 Rs1.81 Billion
≈ $19.59 Million
Rs482.10 Million
≈ $5.21 Million
0.266x +1.48%
2018-03-31 Rs1.45 Billion
≈ $15.68 Million
Rs380.24 Million
≈ $4.11 Million
0.262x -6.41%
2017-03-31 Rs1.24 Billion
≈ $13.43 Million
Rs347.98 Million
≈ $3.76 Million
0.280x +51.04%
2016-03-31 Rs1.05 Billion
≈ $11.34 Million
Rs194.44 Million
≈ $2.10 Million
0.186x -34.69%
2015-03-31 Rs838.58 Million
≈ $9.07 Million
Rs238.21 Million
≈ $2.58 Million
0.284x +129.46%
2014-03-31 Rs762.88 Million
≈ $8.25 Million
Rs94.44 Million
≈ $1.02 Million
0.124x -26.51%
2013-03-31 Rs684.95 Million
≈ $7.41 Million
Rs115.37 Million
≈ $1.25 Million
0.168x -27.37%
2012-03-31 Rs610.60 Million
≈ $6.60 Million
Rs141.61 Million
≈ $1.53 Million
0.232x -14.56%
2011-03-31 Rs479.85 Million
≈ $5.19 Million
Rs130.26 Million
≈ $1.41 Million
0.271x -18.64%
2010-03-31 Rs408.64 Million
≈ $4.42 Million
Rs136.33 Million
≈ $1.47 Million
0.334x +57.34%
2009-03-31 Rs366.47 Million
≈ $3.96 Million
Rs77.71 Million
≈ $840.36K
0.212x -27.97%
2008-03-31 Rs334.69 Million
≈ $3.62 Million
Rs98.53 Million
≈ $1.07 Million
0.294x -30.04%
2007-03-31 Rs279.47 Million
≈ $3.02 Million
Rs117.60 Million
≈ $1.27 Million
0.421x +225.91%
2006-03-31 Rs136.48 Million
≈ $1.48 Million
Rs17.62 Million
≈ $190.56K
0.129x --

About Hester Biosciences Limited

NSE:HESTERBIO India Drug Manufacturers - Specialty & Generic
Market Cap
$189.40 Million
Rs17.51 Billion INR
Market Cap Rank
#16861 Global
#879 in India
Share Price
Rs2058.70
Change (1 day)
+0.30%
52-Week Range
Rs1259.10 - Rs2193.80
All Time High
Rs3204.96
About

Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates through the Poultry Healthcare and Animal Healthcare segments. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal, fowl pox, marek's disease, infectious coryza, fowl cholera, inclusion body hepatitis, fowl… Read more